CompletedNot Applicable

Extent of Intrahepatic Infiltration of Perihilar Cholangiocarcinoma

China62 participantsStarted 2018-04-13

Plain-language summary

The extent of intrahepatic infiltration of perihilar cholangiocarcinoma (PHCC) remains unclear. This research aimed to explore the pattern and extent of intrahepatic infiltration of PHCC to guide surgical treatment and pathological research. This prospective study included 62 participants diagnosed with PHCC who underwent major hepatectomy. A whole-mount digital liver pathology system (WDLPS) for hepatectomy specimens greater than 10 × 10 cm was used to panoramically assess the intrahepatic infiltration extent of PHCC.

Who can participate

Age range44 Years – 81 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients were diagnosed for PHCC based on clinical manifestations, imaging, and pathological findings.
✓. Hepatectomy was performed.
✓. WDLPS was successfully produced.

Exclusion criteria

✕. Not PHCC patients.
✕. Patients with PHCC did not undergo hepatectomy.
✕. WDLPS was not successfully produced.

What they're measuring

Relapse-free survival (RFS).

Timeframe: RFS as of December 2023

Trial details

NCT IDNCT06357117

SponsorBeijing Tsinghua Chang Gung Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-22

View on ClinicalTrials.gov More Perihilar Cholangiocarcinoma trials